Ventzislav Vassilev

Ventzislav Vassilev

Company: GSK

Job title: Senior Director, Vaccine Development Lead


Targeted Immunotherapy for Chronic Hepatitis B (CHB-TI) 2:30 pm

Importance of de novo induction of antigen specific adaptive immunity to CHB Development of novel CHB-TI regimens Status of CHB-TI clinical program and development of synergistic combination modalitiesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.